Governance Before Growth: An Institutional Approach to Healthcare

Posted by - May 27, 2026

In emerging markets, healthcare demand expands faster than governance frameworks. Capital becomes available before oversight matures, technology advances faster than workforce readiness, and growth often outpaces institutional discipline. This is where leadership determines whether expansion becomes transformation or instability. Sakif Shamim, Managing Director of Labaid Cancer Hospital & Super Speciality Centre and Deputy Managing Director

Globalpharma Signs 7 MoUs to Boost UAE Pharma Ecosystem

Posted by - May 25, 2026

Globalpharma, a wholly owned subsidiary of Dubai Investments and one of the UAE’s leading pharmaceutical manufacturers, has signed seven strategic Memorandums of Understanding (MoUs) with leading partners to strengthen its capabilities across research and development, manufacturing optimisation, financing and sustainable operations. The collaborations are structured across three strategic clusters, innovation and product development; manufacturing, efficiency

Scaling Women’s Wellness with Purpose and Integrity

Posted by - May 21, 2026

Amy Suzanne Upchurch’s journey into entrepreneurship was not planned. It was shaped by lived experience, resilience, and an instinctive drive to help other women navigate what she once faced alone. Guided by medical insight and a deep sense of responsibility, she founded Pink Stork in 2015. What began as a small, family-run venture has since

When We Try to Fix What’s Not Broken: Helping ADHD Teens Feel Seen, Not Shamed

Posted by - November 10, 2025

“Can I tell you something?” Her voice was soft; eyes fixed on the floor.“My parents don’t like it when I’m hyper. They think I should top up my medication. Maybe there’s something wrong with me.” Her voice cracked, and tears fell silently, quick, warm, unrestrained, like summer rain.She was sixteen, bright, intense, curious, full of

Latvian Startup Secures €3.3m to Advance Animal-Free Drug Testing

Posted by - August 12, 2025

Riga-based biotech innovator Cellbox Labs has secured €3.3 million in non-dilutive funding to fast-track the development of its dynamic organ-on-a-chip technology, designed to replace animal testing in drug discovery and food science. Part of the capital comes via Tech4Cure, an Important Project of Common European Interest (IPCEI) initiative supporting EU healthcare innovation and industrial resilience.

NHS Rolls Out World-First ‘Trojan Horse’ Therapy for Blood Cancer

Posted by - June 30, 2025

In a landmark move, the National Health Service England (NHS) has become the first health system in the world to roll out a revolutionary ‘Trojan Horse’ therapy for blood cancer. The new treatment, ‘belantamab mafodotin’, is set to transform care for people living with myeloma — an incurable form of blood cancer that affects plasma

Empowering Rural India, One Dose at a Time

Posted by - May 9, 2025

In a landscape often dominated by urban-centric healthcare brands, Winpra Health Care Pvt. Ltd. stands out as a bold and inspiring initiative led by two dynamic young women – Managing Director Aswini C, who is also a trained pharmacist and Chairperson Prarthanaa K, an aspiring corporate leader with a background in finance. Their shared dream?

Wellness 2.O: Transforming Healthcare with Lifestyle Medicine

Posted by - March 21, 2025

The healthcare and wellness industry is undergoing a massive transformation. We are entering an era of Wellness 2.0, shifting from a reactive, disease-management model to a proactive, integrative, and holistic approach that prioritises prevention, root-cause healing, and sustainable well-being. Consumers are no longer willing to accept short-term fixes—they want lasting solutions. Health is no longer

BioTech Startup Akribion Raises €8m for Programmable Cell Depletion

Posted by - February 6, 2025

Akribion Therapeautics, a Zwingenberg-based BioTech startup developing a RNA-guided, nuclease-based technology for programmable cell depletion, recently announced its exit from stealth and the completion of a Seed financing round raising €8 million to accelerate the development of therapeutics based on Akribion’s proprietary G-dase® E nucleases. The round was led by CARMA FUND and RV Invest,

Berlin-based Startup Nelly Raises €50 million

Posted by - January 20, 2025

Berlin-based Nelly, a rising startup at the intersection of health and fintech, has secured €50 million in a Series B funding round to enter new European markets and develop new products. Led by Cathay Innovation and Notion Capital, the round also included existing investors b2venture, Lakestar, Motive Ventures, and Arc Investors. The funding positions Nelly

live Now